Skip to main content
Clinical Trials/NCT06336460
NCT06336460
Not yet recruiting
Not Applicable

Pericapsular Nerve Group (PENG) Block vs. the Fascia Iliaca Compartment (FIC) Block for Patients With Isolated Hip Fractures in the Emergency Department

Orange Park Medical Center0 sites60 target enrollmentApril 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hip Fractures
Sponsor
Orange Park Medical Center
Enrollment
60
Primary Endpoint
Numeric pain score at 30 minutes
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study is a prospective, randomized clinical trial assessing the efficacy of physician-performed ultrasound-guided pericapsular nerve group (PENG) block vs fascia iliaca compartment (FIC) block for pain control in acute hip fracture.

Registry
clinicaltrials.gov
Start Date
April 1, 2024
End Date
April 1, 2026
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult (\>= 18 years of age)
  • Isolated proximal hip fracture (defined as Intertrochanteric or more proximal) as identified by X-ray, Computed Tomography (CT) scan or Magnetic Resonance Imaging (MRI) scan
  • Glasgow Coma Score (GCS) = 15
  • Subjective pain score of \>= 5 on a scale of 0 to 10 just prior to the nerve block placement

Exclusion Criteria

  • Patients who are unable to give consent due to altered mental status or dementia
  • Clinically intoxicated patients
  • Patients who are unable to communicate their numeric level of pain
  • Open fracture or penetrating hip trauma
  • Signs of infection or laceration at injection site
  • Patients with multi-system trauma
  • Painful distracting injury (injury causing significant pain that distracts the patient from having reliable scoring of hip fracture pain, e.g. humerus fracture, dislocated joint)
  • Requiring immediate surgical intervention (\< 1 hour)
  • Deemed clinically unstable by treating physician
  • Abnormal vital signs (Pulse\>120bpm, Systolic blood pressure \< 100 mm Hg, Pulse O2 \< 95%)

Outcomes

Primary Outcomes

Numeric pain score at 30 minutes

Time Frame: 30 minutes after block placement

Numeric pain score at 60 minutes

Time Frame: 1 hour after block placement

Secondary Outcomes

  • Cumulative Morphine Milligram Equivalents in 24 hours after enrollment(24 hours after enrollment)

Similar Trials